Tiburio Therapeutics

OverviewSuggest Edit

Tiburio Therapeutics is a biopharmaceutical company, which is dedicated to advancing novel treatments for rare neuroendocrine tumors and rare endocrine diseases. The Company's pipeline consists of two clinical stage compounds: TBR-760 for the treatment of non-functioning pituitary adenoma, and TBR-065 for additional rare endocrine diseases.

TypePrivate
Founded2018
HQCambridge, MA, US
Websitetiburio.com

Locations

Tiburio Therapeutics is headquartered in
Cambridge, United States

Location Map

Latest Updates

Employees (est.) (Apr 2021)7(-22%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Tiburio Therapeutics

Chris Adams

Chris Adams

Director
Sandip K. Agarwala

Sandip K. Agarwala

Director
Michael D. Culler

Michael D. Culler

Scientific Founder and Chairman, Scientific Advisory Board
Mette Kirstine Agger

Mette Kirstine Agger

Director
Abraham N. Ceesay

Abraham N. Ceesay

Chief Executive Officer, Director
Joel S. Marcus

Joel S. Marcus

Board Observer
Show more

Tiburio Therapeutics Office Locations

Tiburio Therapeutics has an office in Cambridge
Cambridge, MA, US (HQ)
NE48, 700 Technology Square 2nd Floor
Show all (1)

Tiburio Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2018

Tiburio Therapeutics total Funding

$31 m

Tiburio Therapeutics latest funding size

$31 m

Time since last funding

3 years ago

Tiburio Therapeutics investors

Tiburio Therapeutics's latest funding round in January 2019 was reported to be $31 m. In total, Tiburio Therapeutics has raised $31 m
Show all financial metrics

Tiburio Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Tiburio Therapeutics Online and Social Media Presence

Embed Graph

Tiburio Therapeutics Frequently Asked Questions

  • When was Tiburio Therapeutics founded?

    Tiburio Therapeutics was founded in 2018.

  • Who are Tiburio Therapeutics key executives?

    Tiburio Therapeutics's key executives are Chris Adams, Sandip K. Agarwala and Michael D. Culler.

  • How many employees does Tiburio Therapeutics have?

    Tiburio Therapeutics has 7 employees.

  • Who are Tiburio Therapeutics competitors?

    Competitors of Tiburio Therapeutics include LimmaTech Biologics, Biosyntia and Eikon Therapeutics.

  • Where is Tiburio Therapeutics headquarters?

    Tiburio Therapeutics headquarters is located at NE48, 700 Technology Square 2nd Floor, Cambridge.

  • Where are Tiburio Therapeutics offices?

    Tiburio Therapeutics has an office in Cambridge.

  • How many offices does Tiburio Therapeutics have?

    Tiburio Therapeutics has 1 office.